Alliances
Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene therapies for two rare diseases.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 1, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 26, 2020.
The companies will work to discover, develop and commercialize novel therapies that modulate G protein-coupled receptor (GPCR) targets that AbbVie selects.
ring to push boundaries, upend limitations, and put mankind on the moon. In a strategic new alignment, Van Heron Labs, a startup formed in Houston, will begin working alongside Huntsville’s Foresight Biosciences to continue the tradition.
Yumanity Therapeutics and Merck signed a strategic research and license deal for two Yumanity programs.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 24, 2020.
The diagnostic tool will use Thermo Fisher’s next-generation sequencing (NGS)-based Oncomine Dx Target Test to identify HER2 (human epidermal growth factor receptor 2) gene mutations.
Sanofi Pasteur and Translate Bio announced the expansion of an existing collaboration to develop mRNA vaccines for infectious diseases. The original deal was entered in 2018.
PRESS RELEASES